massive bone allograft
Recently Published Documents


TOTAL DOCUMENTS

16
(FIVE YEARS 3)

H-INDEX

8
(FIVE YEARS 0)

2015 ◽  
Vol 39 (6) ◽  
pp. 1151-1158 ◽  
Author(s):  
Zhigang Wu ◽  
Jun Fu ◽  
Zhen Wang ◽  
Xiangdong Li ◽  
Jing Li ◽  
...  

Sarcoma ◽  
2013 ◽  
Vol 2013 ◽  
pp. 1-8 ◽  
Author(s):  
Katharina Rabitsch ◽  
Werner Maurer-Ertl ◽  
Ulrike Pirker-Frühauf ◽  
Christine Wibmer ◽  
Andreas Leithner

Reconstruction with massive bone allograft and autologous vascularised fibula combines the structural strength of the allograft and the advantages of fibula’s intrinsic blood supply. We retrospectively analysed the outcome of twelve patients (4 male, 8 female) who received reconstruction with massive bone allograft and autologous vascularised fibula after tumour resection in lower limb. Mean age was 17.8 years (range 11–31 years), with following primaries: Ewing’s sarcoma (n=6), osteosarcoma (n=4), liposarcoma grade 2 (n=1), and adamantinoma (n=1). Mean followup was 38.7 months (median 25.7 months; range 2–88 months). Seven tumours were located in the femur and five in the tibia. The mean length of bone defect was 18.7 cm (range 15–25 cm). None of the grafts had to be removed, but there occurred four fractures, four nonunions, and two infections. Two patients developed donor side complication, in form of flexion deformity of the big toe. The event-free survival rate was 51% at two-year followup and 39% at three- and five-year followup. As the complications were manageable, and full weight bearing was achieved in all cases, we consider the combination of massive bone allograft and autologous vascularised fibula a stable and durable reconstruction method of the diaphysis of the lower limbs.


2011 ◽  
Vol 1 (2) ◽  
pp. e10 ◽  
Author(s):  
Pierre-Louis Docquier ◽  
Olivier Cartiaux ◽  
Laurent Paul ◽  
Christian Delloye ◽  
Xavier Banse

Sign in / Sign up

Export Citation Format

Share Document